Skip to content
★ Sign in to follow
VS

Vladislav Sandler

Hemogenyx Pharmaceuticals PLC
Total declarations
1
Company
1
▲ Purchases (1 ops.)
€720
▼ Sales (0 ops.)
—

Latest filing published 07 Feb 2018 for Hemogenyx Pharmaceuticals PLC, €720.

Filing timeline

BuySale
Vladislav Sandler

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Vladislav Sandler: trading record in brief

Our data holds just one disclosure by Vladislav Sandler, dated 7 February 2018, reporting an open-market purchase worth €720 in Hemogenyx Pharmaceuticals PLC. Further filings will be added here. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Companies and markets linked to Vladislav Sandler

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    Chief Executive Officer and Co-FounderExecutivesHemogenyx Pharmaceuticals PLC
    635 GBP0FCA-NSM
    26,800 shares@ £0.0237London Stock ExchangeISIN GB00BYX3WZ24FCA-NSM:LSE20180207070003_13524031_20200330111413568_22247
    Canonical exit: 6 May 2018 (T+90)

1 of 1 declaration